​

Funding Round

Series A - Naveris

Series A - Naveris

Investment Firm

Overview

Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.

Announced Date

Sep 19, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Gurnet Point Capital

Gurnet Point Capital

Gurnet Point Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

3

Investor Name
Participant InvestorBrightEdge Fund
Participant InvestorTechU Ventures
Participant InvestorGurnet Point Capital

Round Details and Background

Naveris raised $33400000 on 2022-09-19 in Series A

Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 28, 2020
Venture Round - Naveris
-15.4M
Dec 15, 2020
Series A - Naveris
3-undefined
Sep 19, 2022
Series A - Naveris
3-33.4M
Jul 02, 2024
Venture Round - Naveris
-17.5M

Recent Activity

News

Sep 19, 2022

gurnetpointcapital.com - Naveris, Inc. Raises $51 Million to Advance Commercialization of NavDx